|
1
|
Wu X, Cai J, Zuo Z and Li J: Collagen
facilitates the colorectal cancer stemness and metastasis through
an integrin/PI3K/AKT/Snail signaling pathway. Biomed Pharmacother.
114:1087082019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nissen NI, Kehlet S, Boisen MK, Liljefors
M, Jensen C, Johansen AZ, Johansen JS, Erler JT, Karsdal M,
Mortensen JH, et al: Prognostic value of blood-based fibrosis
biomarkers in patients with metastatic colorectal cancer receiving
chemotherapy and bevacizumab. Sci Rep. 11:1–12. 2021. View Article : Google Scholar
|
|
3
|
Longley DB, Harkin DP and Johnston PG:
5-fluorouracil: Mechanisms of action and clinical strategies. Nat
Rev Cancer. 3:330–338. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Iacovelli R, Pietrantonio F, Maggi C, de
Braud F and Di Bartolomeo M: Combination or single-agent
chemotherapy as adjuvant treatment of gastric cancer: A systematic
review and meta-analysis of published trials. Crit Rev Oncol
Hematol. 98:24–28. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Iacovelli R, Pietrantonio F, Palazzo A,
Maggi C, Ricchini F, de Braud F and Di Bartolomeo M: Incidence and
relative risk of grade 3 and 4 diarrhoea in patients treated with
capecitabine or 5-fluorouracil: A meta-analysis of published
trials. Br J Clin Pharmacol. 78:1228–1237. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jang BS, Park HJ, Kim K, Jang JY, Kim SW,
Oh DY and Chie EK: Role of adjuvant chemoradiotherapy for duodenal
cancer: An updated analysis of long-term follow-up from single
institution. World J Surg. 42:3294–3301. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lee JJ, Beumer JH and Chu E: Therapeutic
drug monitoring of 5-fluorouracil. Cancer Chemother Pharmacol.
78:447–464. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sougiannis AT, VanderVeen BN, Enos RT,
Velazquez KT, Bader JE, Carson M, Chatzistamou I, Walla M, Pena MM,
Kubinak JL, et al: Impact of 5 fluorouracil chemotherapy on gut
inflammation, functional parameters, and gut microbiota. Brain
Behav Immun. 80:44–55. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Siegel R, DeSantis C and Jemal A:
Colorectal cancer statistics, 2014. CA Cancer J Clin. 64:104–117.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lengerich EJ, Wyatt SW, Rubio A, Beaulieu
JE, Coyne CA, Fleisher L, Ward AJ and Brown PK: The appalachia
cancer network: Cancer control research among a rural, medically
underserved population. J Rural Health. 20:181–187. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Blackley D, Behringer B and Zheng S:
Cancer mortality rates in Appalachia: Descriptive epidemiology and
an approach to explaining differences in outcomes. J Community
Health. 37:804–813. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Augustus GJ and Ellis NA: Colorectal
cancer disparity in African Americans: Risk factors and
carcinogenic mechanisms. Am J Pathol. 188:291–303. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lengerich EJ, Tucker TC, Powell RK,
Colsher P, Lehman E, Ward AJ, Siedlecki JC and Wyatt SW: Cancer
incidence in Kentucky, Pennsylvania, and West Virginia: Disparities
in appalachia. J Rural Health. 21:39–47. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wingo PA, Tucker TC, Jamison PM, Martin H,
McLaughlin C, Bayakly R, Bolick-Aldrich S, Colsher P, Indian R,
Knight K, et al: Cancer in Appalachia, 2001–2003. Cancer.
112:181–192. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Doubeni CA, Major JM, Laiyemo AO,
Schootman M, Zauber AG, Hollenbeck AR, Sinha R and Allison J:
Contribution of behavioral risk factors and obesity to
socioeconomic differences in colorectal cancer incidence. J Natl
Cancer Inst. 104:1353–1362. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fleming ST, Mackley HB, Camacho F, Seiber
EE, Gusani NJ, Matthews SA, Liao J, Yang TC, Hwang W and Yao N:
Clinical, sociodemographic, and service provider determinants of
guideline concordant colorectal cancer care for Appalachian
residents. J Rural Health. 30:27–39. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Paskett ED, Fisher JL, Lengerich EJ,
Schoenberg NE, Kennedy SK, Conn ME, Roberto KA, Dwyer SK, Fickle D
and Dignan M: Disparities in underserved white populations: The
case of cancer-related disparities in Appalachia. Oncologist.
16:1072–1081. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Alexander DD, Waterbor J, Hughes T,
Funkhouser E, Grizzle W and Manne U: African-American and Caucasian
disparities in colorectal cancer mortality and survival by data
source: An epidemiologic review. Cancer Biomark. 3:301–313. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tapan U, Lee SY, Weinberg J, Kolachalama
VB, Francis J, Charlot M, Hartshorn K and Chitalia V: Racial
differences in colorectal cancer survival at a safety net hospital.
Cancer Epidemiol. 49:30–37. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Le CC, Bennasroune A, Langlois B, Salesse
S, Boulagnon-Rombi C, Morjani H, Dedieu S and Appert-Collin A:
Functional interplay between collagen network and cell behavior
within tumor microenvironment in colorectal cancer. Front Oncol.
10:5272020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zou X, Feng B, Dong T, Yan G, Tan B, Shen
H, Huang A, Zhang X, Zhang M, Yang P, et al: Up-regulation of type
I collagen during tumorigenesis of colorectal cancer revealed by
quantitative proteomic analysis. J Proteomics. 94:473–485. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kuipers EJ, Grady WM, Lieberman D,
Seufferlein T, Sung JJ, Boelens PG, van de Velde CJ and Watanabe T:
Colorectal cancer. Nat Rev Dis Primers. 1:150652015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shi R, Gao S, Zhang J, Xu J, Graham LM,
Yang X and Li C: Collagen prolyl 4-hydroxylases modify tumor
progression. Acta Biochim Biophys Sin (Shanghai). 53:805–814. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Oh BY, Kim KH, Chung SS, Hong KS and Lee
RA: Role of β1-integrin in colorectal cancer: Case-control study.
Ann Coloproctol. 30:61–70. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Said AH, Raufman JP and Xie G: The role of
matrix metalloproteinases in colorectal cancer. Cancers (Basel).
6:366–375. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jeitany M, Leroy C, Tosti P, Lafitte M, Le
Guet J, Simon V, Bonenfant D, Robert B, Grillet F, Mollevi C, et
al: Inhibition of DDR 1-BCR signalling by nilotinib as a new
therapeutic strategy for metastatic colorectal cancer. EMBO Mol
Med. 10:e79182018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tanaka A, Zhou Y, Shia J, Ginty F, Ogawa
M, Klimstra DS, Hendrickson RC, Wang JY and Roehrl MH: Prolyl
4-hydroxylase alpha 1 protein expression risk-stratifies early
stage colorectal cancer. Oncotarget. 11:813–824. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Murray GI, Duncan ME, O'Neil P, Melvin WT
and Fothergill JE: Matrix metalloproteinase-1 is associated with
poor prognosis in colorectal cancer. Nat Med. 2:461–462. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kirkland SC: Type I collagen inhibits
differentiation and promotes a stem cell-like phenotype in human
colorectal carcinoma cells. Br J Cancer. 101:320–326. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Miyazaki K, Togo S, Okamoto R, Idiris A,
Kumagai H and Miyagi Y: Collective cancer cell invasion in contact
with fibroblasts through integrin-α5β1/fibronectin interaction in
collagen matrix. Cancer Sci. 111:4381–4392. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Karagiannis GS, Petraki C, Prassas I,
Saraon P, Musrap N, Dimitromanolakis A and Diamandis EP: Proteomic
signatures of the desmoplastic invasion front reveal collagen type
XII as a marker of myofibroblastic differentiation during
colorectal cancer metastasis. Oncotarget. 3:267–285. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Brauchle E, Kasper J, Daum R, Schierbaum
N, Falch C, Kirschniak A, Schäffer TE and Schenke-Layland K:
Biomechanical and biomolecular characterization of extracellular
matrix structures in human colon carcinomas. Matrix Biol. 68–69.
180–193. 2018.
|
|
33
|
Egeblad M, Rasch MG and Weaver VM: Dynamic
interplay between the collagen scaffold and tumor evolution. Curr
Opin Cell Biol. 22:697–706. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Levental KR, Yu H, Kass L, Lakins JN,
Egeblad M, Erler JT, Fong SF, Csiszar K, Giaccia A, Weninger W, et
al: Matrix crosslinking forces tumor progression by enhancing
integrin signaling. Cell. 139:891–906. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Solé X, Crous-Bou M, Cordero D, Olivares
D, Guinó E, Sanz-Pamplona R, Rodriguez-Moranta F, Sanjuan X, de Oca
J, Salazar R and Moreno V: Discovery and validation of new
potential biomarkers for early detection of colon cancer. PLoS One.
9:e1067482014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bonde A, Smith DA, Kikano E, Yoest JM,
Tirumani SH and Ramaiya NH: Overview of serum and tissue markers in
colorectal cancer: A primer for radiologists. Abdom Radiol (NY).
46:5521–5535. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lalmahomed ZS, Bröker ME, van Huizen NA,
van den Braak RRJC, Dekker LJ, Rizopoulos D, Verhoef C, Steyerberg
EW, Luider TM and Ijzermans JNM: Hydroxylated collagen peptide in
urine as biomarker for detecting colorectal liver metastases. Am J
Cancer Res. 6:321–330. 2016.PubMed/NCBI
|
|
38
|
Kehlet SN, Sanz-Pamplona R, Brix S,
Leeming DJ, Karsdal MA and Moreno V: Excessive collagen turnover
products are released during colorectal cancer progression and
elevated in serum from metastatic colorectal cancer patients. Sci
Rep. 6:305992016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Qiu J, Jiang W, Yang Y, Feng C, Chen Z,
Guan G, Zhuo S and Chen J: Monitoring changes of tumor
microenvironment in colorectal submucosa using multiphoton
microscopy. Scanning. 37:17–22. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chen W, Dong S, Liu X, Wang G, Xu S, Lei
S, Zhuo S and Yan J: Association of the collagen signature in the
tumor microenvironment with recurrence and survival of patients
with T4N0M0 colon cancer. Dis Colon Rectum. 64:563–575. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhuo S, Yan J, Chen G, Shi H, Zhu X, Lu J,
Chen J and Xie S: Label-free imaging of basement membranes
differentiates normal, precancerous, and cancerous colonic tissues
by second-harmonic generation microscopy. PLoS One. 7:e386552012.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Liu N, Chen J, Xu R, Jiang S, Xu J and
Chen R: Label-free imaging characteristics of colonic mucinous
adenocarcinoma using multiphoton microscopy. Scanning. 35:277–282.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Xia G, Zhi W, Zou Y, Wang L, Wang C, Peng
R and Hu X: Non-linear optical imaging and quantitative analysis of
the pathological changes in normal and carcinomatous human
colorectal muscularis. Pathology. 49:627–632. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Nallala J, Jeynes C, Saunders S, Smart N,
Lloyd G, Riley L, Salmon D and Stone N: Characterization of
colorectal mucus using infrared spectroscopy: A potential target
for bowel cancer screening and diagnosis. Lab Invest.
100:1102–1110. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Brozek-Pluska B, Musial J, Kordek R and
Abramczyk H: Analysis of human colon by raman spectroscopy and
imaging-elucidation of biochemical changes in carcinogenesis. Int J
Mol Sci. 20:33982019. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Farrar CT, Gale EM, Kennan R, Ramsay I,
Masia R, Arora G, Looby K, Wei L, Kalpathy-Cramer J, Bunzel MM, et
al: CM-101: Type I collagen-targeted MR imaging probe for detection
of liver fibrosis. Radiology. 287:581–589. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Caravan P, Das B, Dumas S, Epstein FH,
Helm PA, Jacques V, Koerner S, Kolodziej A, Shen L, Sun WC and
Zhang Z: Collagen-targeted MRI contrast agent for molecular imaging
of fibrosis. Angew Chem Int Ed Engl. 46:8171–8173. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Sarri B, Canonge R, Audier X, Simon E,
Wojak J, Caillol F, Cador C, Marguet D, Poizat F, Giovannini M and
Rigneault H: Fast stimulated Raman and second harmonic generation
imaging for intraoperative gastro-intestinal cancer detection. Sci
Rep. 9:100522019. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Angel PM, Comte-Walters S, Ball LE, Talbot
K, Mehta A, Brockbank KGM and Drake RR: Mapping extracellular
matrix proteins in formalin-fixed, paraffin-embedded tissues by
MALDI imaging mass spectrometry. J Proteome Res. 17:635–646. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Angel PM, Schwamborn K, Comte-Walters S,
Clift C, Ball LE, Mehta AS and Drake RR: Extracellular matrix
imaging of breast tissue pathologies by MALDI imaging mass
spectrometry. Proteomics Clin Appl. 13:e17001522019. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Angel PM, Bruner E, Bethard J, Clift CL,
Ball L, Drake RR and Feghali-Bostwick C: Extracellular matrix
alterations in low-grade lung adenocarcinoma compared with normal
lung tissue by imaging mass spectrometry. J Mass Spectrom.
55:e44502020. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Angel PM, Bruner E, Clift CL, Bethard JB,
Ball LE, Drake RR and Feghali-Bostwick C: Extracellular matrix
alterations in low grade lung adenocarcinoma compared to normal
lung tissue by imaging mass spectrometry. J Mass Spectrom.
55:e44502019. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Angel PM, Spruill L, Jefferson M, Bethard
JR, Ball LE, Hughes-Halbert C and Drake RR: Zonal regulation of
collagen-type proteins and posttranslational modifications in
prostatic benign and cancer tissues by imaging mass spectrometry.
Prostate. 80:1071–1086. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Clift CL, Su YR, Bichell D, Smith HCJ,
Bethard JR, Norris-Caneda K, Comte-Walters S, Ball LE,
Hollingsworth MA, Mehta AS, et al: Collagen fiber regulation in
human pediatric aortic valve development and disease. Sci Rep.
11:1–17. 2021. View Article : Google Scholar
|
|
55
|
Saeed AI, Bhagabati NK, Braisted JC, Liang
W, Sharov V, Howe EA, Li J, Thiagarajan M, White JA and Quackenbush
J: TM4 microarray software suite. Methods Enzymol. 411:134–193.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Rujchanarong D, Lefler J, Saunders JE,
Pippin S, Spruill L, Bethard JR, Ball LE, Mehta AS, Drake RR,
Ostrowski MC and Angel PM: Defining the tumor microenvironment by
integration of immunohistochemistry and extracellular matrix
targeted imaging mass spectrometry. Cancers (Basel). 13:44192021.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Angel PM and Zambrzycki SC: Predictive
value of collagen in cancer. Adv Cancer Res. 154:15–45. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Compton CC, Byrd DR, Garcia-Aguilar J,
Kurtzman SH, Olawaiye A and Washington MK: AJCC cancer staging
atlas: A companion to the seventh editions of the AJCC cancer
staging manual and handbook. Springer Science & Business Media;
2012, View Article : Google Scholar
|
|
59
|
Pai RK, Bettington M, Srivastava A and
Rosty C: An update on the morphology and molecular pathology of
serrated colorectal polyps and associated carcinomas. Mod Pathol.
32:1390–1415. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Gimon TI, Dykstra MA, Chezar K, Buie WD
and MacLean A: Malignant colorectal polyp pathology: Are we getting
sufficient information to make decisions? Dis Colon Rectum.
63:135–142. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Freeman HJ: Early stage colon cancer.
World J Gastroenterol. 19:8468–8473. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Johncilla M and Yantiss RK: Histology of
colorectal carcinoma: Proven and purported prognostic factors. Surg
Pathol Clin. 13:503–520. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
van Pelt GW, Sandberg TP, Morreau H,
Gelderblom H, van Krieken JHJM, Tollenaar RAEM and Mesker WE: The
tumour-stroma ratio in colon cancer: The biological role and its
prognostic impact. Histopathology. 73:197–206. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Nyström H: Extracellular matrix proteins
in metastases to the liver-composition, function and potential
applications. Semin Cancer Biol. 71:134–142. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Winslow S, Lindquist KE, Edsjö A and
Larsson C: The expression pattern of matrix-producing tumor stroma
is of prognostic importance in breast cancer. BMC Cancer.
16:8412016. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
van Huizen NA, Burgers PC, van Rosmalen J,
Doukas M, IJzermans JNM and Luider TM: Down-regulation of collagen
hydroxylation in colorectal liver metastasis. Front Oncol.
10:5577372020. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Gjaltema RA and Bank RA: Molecular
insights into prolyl and lysyl hydroxylation of fibrillar collagens
in health and disease. Crit Rev Biochem Mol Biol. 52:74–95. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Tanjore H and Kalluri R: The role of type
IV collagen and basement membranes in cancer progression and
metastasis. Am J Pathol. 168:715–717. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Ikeda K, Iyama KI, Ishikawa N, Egami H,
Nakao M, Sado Y, Ninomiya Y and Baba H: Loss of expression of type
IV collagen α5 and α6 chains in colorectal cancer associated with
the hypermethylation of their promoter region. Am J Pathol.
168:856–865. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Sweeney SM, Orgel JP, Fertala A, McAuliffe
JD, Turner KR, Di Lullo GA, Chen S, Antipova O, Perumal S,
Ala-Kokko L, et al: Candidate cell and matrix interaction domains
on the collagen fibril, the predominant protein of vertebrates. J
Biol Chem. 283:21187–21197. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Emsley J, Knight CG, Farndale RW, Barnes
MJ and Liddington RC: Structural basis of collagen recognition by
integrin alpha2beta1. Cell. 101:47–56. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Zhao Y, Marcink TC, Gari RRS, Marsh BP,
King GM, Stawikowska R, Fields GB and Van Doren SR: Transient
collagen triple helix binding to a key metalloproteinase in
invasion and development. Structure. 23:257–269. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Coelho NM, Wang A and McCulloch CA:
Discoidin domain receptor 1 interactions with myosin motors
contribute to collagen remodeling and tissue fibrosis. Biochim
Biophys Acta Mol Cell Res. 1866:1185102019. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Ichikawa O, Osawa M, Nishida N, Goshima N,
Nomura N and Shimada I: Structural basis of the collagen-binding
mode of discoidin domain receptor 2. EMBO J. 26:4168–4176. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Shoulders MD and Raines RT: Collagen
structure and stability. Ann Rev Biochem. 78:929–958. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Gorres KL and Raines RT: Prolyl
4-hydroxylase. Crit Rev Biochem Mol Biol. 45:106–124. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Liang Y, Lv Z, Huang G, Qin J, Li H, Nong
F and Wen B: Prognostic significance of abnormal matrix collagen
remodeling in colorectal cancer based on histologic and
bioinformatics analysis. Oncol Rep. 44:1671–1685. 2020.PubMed/NCBI
|
|
78
|
Agarwal S, Behring M, Kim HG, Bajpai P,
Chakravarthi BVSK, Gupta N, Elkholy A, Al Diffalha S, Varambally S
and Manne U: Targeting P4HA1 with a small molecule inhibitor in a
colorectal cancer PDX model. Transl Oncol. 13:1007542020.
View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Hannan LM, Jacobs EJ and Thun MJ: The
association between cigarette smoking and risk of colorectal cancer
in a large prospective cohort from the United States. Cancer
Epidemiol Biomarkers Prev. 18:3362–3367. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Rujchanarong D, Scott D, Park Y, Brown S,
Mehta AS, Drake R, Sandusky GE, Nakshatri H and Angel PM: Metabolic
links to socioeconomic stresses uniquely affecting ancestry in
normal breast tissue at risk for breast cancer. Front Oncol.
12:8766512022. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Karlamangla AS, Merkin SS, Crimmins EM and
Seeman TE: Socioeconomic and ethnic disparities in cardiovascular
risk in the United States, 2001–2006. Ann Epidemiol. 20:617–628.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Robinson O, Carter AR, Ala-Korpela M,
Casas JP, Chaturvedi N, Engmann J, Howe LD, Hughes AD, Järvelin MR,
Kähönen M, et al: Metabolic profiles of socio-economic position: A
multi-cohort analysis. Int J Epidemiol. 50:768–782. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Wyckoff JB, Wang Y, Lin EY, Li JF, Goswami
S, Stanley ER, Segall JE, Pollard JW and Condeelis J: Direct
visualization of macrophage-assisted tumor cell intravasation in
mammary tumors. Cancer Res. 67:2649–2656. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Estes RJ, Goins JH, Ferguson P and Crain
JL: Melungeons, a multi-ethnic population. J Genetic Genealogy.
7:1–108. 2011.
|
